Chemoinformaics analysis of (2E)-N-methyl-3-phenyl-N-[(E)-2-phenylethenyl]prop-2-enamide
Molecular Weight | 263.34 | nRot | 4 |
Heavy Atom Molecular Weight | 246.204 | nRig | 15 |
Exact Molecular Weight | 263.131 | nRing | 2 |
Solubility: LogS | -5.144 | nHRing | 0 |
Solubility: LogP | 3.623 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 2 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 17 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 12 |
No. of Oxygen atom | 1 | No. of Arom Bond | 12 |
nHA | 1 | APOL | 43.2975 |
nHD | 0 | BPOL | 19.6325 |
QED | 0.768 |
Synth | 2.255 |
Natural Product Likeliness | 0.277 |
NR-PPAR-gamma | 0.884 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.534 |
Pgp-sub | 0.001 |
HIA | 0.023 |
CACO-2 | -4.715 |
MDCK | 0.0000154 |
BBB | 0.914 |
PPB | 0.954482 |
VDSS | 0.377 |
FU | 0.031559 |
CYP1A2-inh | 0.98 |
CYP1A2-sub | 0.78 |
CYP2c19-inh | 0.861 |
CYP2c19-sub | 0.186 |
CYP2c9-inh | 0.666 |
CYP2c9-sub | 0.955 |
CYP2d6-inh | 0.163 |
CYP2d6-sub | 0.808 |
CYP3a4-inh | 0.113 |
CYP3a4-sub | 0.351 |
CL | 3.928 |
T12 | 0.419 |
hERG | 0.317 |
Ames | 0.417 |
ROA | 0.018 |
SkinSen | 0.873 |
Carcinogencity | 0.739 |
EI | 0.95 |
Respiratory | 0.196 |
NR-Aromatase | 0.557 |
Antiviral | No |
Prediction | 0.714211 |